08:57 AM EDT, 06/28/2024 (MT Newswires) -- Health care stocks were gaining pre-bell Friday, with the Health Care Select Sector SPDR Fund ( XLV ) and the iShares Biotechnology ETF ( IBB ) up 0.4%.

Carisma Therapeutics ( CARM ) said late Thursday that it nominated an in vivo CAR-M targeting Glypican-3 as the first development candidate under its collaboration with Moderna ( MRNA ) . Carisma shares rose 32% and Moderna ( MRNA ) shares were up 1.3% pre-bell Friday.

Gain Therapeutics ( GANX ) said late Thursday that it appointed Chief Financial Officer Gene Mack as interim chief executive, effective earlier this week, following the departure of CEO Matthias Alder. The company's shares were down 15% pre-bell Friday.

Elicio Therapeutics ( ELTX ) shares fell 37% after the company said it has launched an underwritten public offering of its shares and accompanying warrant.